DK400887A - Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel - Google Patents

Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel

Info

Publication number
DK400887A
DK400887A DK400887A DK400887A DK400887A DK 400887 A DK400887 A DK 400887A DK 400887 A DK400887 A DK 400887A DK 400887 A DK400887 A DK 400887A DK 400887 A DK400887 A DK 400887A
Authority
DK
Denmark
Prior art keywords
preparation
deoxyspergualin
medicinal product
medicinal
product
Prior art date
Application number
DK400887A
Other languages
English (en)
Other versions
DK175078B1 (da
DK400887D0 (da
Inventor
Gerhard Dickneite
Hans-Ulrich Schorlemmer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK400887D0 publication Critical patent/DK400887D0/da
Publication of DK400887A publication Critical patent/DK400887A/da
Application granted granted Critical
Publication of DK175078B1 publication Critical patent/DK175078B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treating Waste Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198704008A 1986-08-02 1987-07-31 Anvendelse af 15-deoxyspergualin til fremstilling af et lægemiddel til terapeutisk behandling af degenerative sygdomme i centralnervesystemet DK175078B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3626306 1986-08-02
DE19863626306 DE3626306A1 (de) 1986-08-02 1986-08-02 Verwendung von 15-deoxyspergualin als arzneimittel

Publications (3)

Publication Number Publication Date
DK400887D0 DK400887D0 (da) 1987-07-31
DK400887A true DK400887A (da) 1988-02-03
DK175078B1 DK175078B1 (da) 2004-05-24

Family

ID=6306627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704008A DK175078B1 (da) 1986-08-02 1987-07-31 Anvendelse af 15-deoxyspergualin til fremstilling af et lægemiddel til terapeutisk behandling af degenerative sygdomme i centralnervesystemet

Country Status (13)

Country Link
US (1) US4847299A (da)
EP (1) EP0256385B1 (da)
JP (1) JP2610621B2 (da)
KR (1) KR950013453B1 (da)
AT (1) ATE130192T1 (da)
AU (1) AU605494B2 (da)
CA (1) CA1305424C (da)
DE (2) DE3626306A1 (da)
DK (1) DK175078B1 (da)
ES (1) ES2081279T3 (da)
GR (1) GR3018365T3 (da)
PT (1) PT85454B (da)
ZA (1) ZA875676B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002756A (en) * 1988-04-04 1991-03-26 Zaidanhojin Biseibutsu Kagakukenkyukai Method for relieving radiogenic or drug-induced side effects
JPH0211514A (ja) * 1988-06-30 1990-01-16 Takara Shuzo Co Ltd スパガリン類製剤
DE59504374D1 (de) * 1994-03-22 1999-01-14 Nippon Kayaku Kk Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
US5985824A (en) * 1997-02-27 1999-11-16 Genzyme Corporation Methods and compositions for treating cystic fibrosis
US6294581B1 (en) * 1998-05-15 2001-09-25 Takara Shuzo Co., Ltd. Inhibition of IgA production
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58198455A (ja) * 1982-05-17 1983-11-18 Microbial Chem Res Found （−）−１５−デオキシスパガリンおよびその製造法並びにその中間体
US4525299A (en) * 1983-05-10 1985-06-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (-)-15-Deoxyspergualin, process for the preparation thereof, and intermediate of the same
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
DE3508033A1 (de) * 1985-03-07 1986-09-11 Behringwerke Ag, 3550 Marburg Verwendung von (-)-15-deoxyspergualin als immunsuppressor
WO1987002583A1 (en) * 1985-10-29 1987-05-07 The Rockefeller University Treatment of demyelinating diseases

Also Published As

Publication number Publication date
KR950013453B1 (en) 1995-11-08
PT85454B (pt) 1990-06-29
KR880002535A (ko) 1988-05-09
US4847299A (en) 1989-07-11
DK175078B1 (da) 2004-05-24
EP0256385A2 (de) 1988-02-24
DE3751597D1 (de) 1995-12-21
DE3626306A1 (de) 1988-02-11
AU7633987A (en) 1988-02-04
CA1305424C (en) 1992-07-21
JP2610621B2 (ja) 1997-05-14
GR3018365T3 (en) 1996-03-31
PT85454A (de) 1987-08-01
EP0256385B1 (de) 1995-11-15
JPS6341419A (ja) 1988-02-22
EP0256385A3 (de) 1992-04-01
AU605494B2 (en) 1991-01-17
ATE130192T1 (de) 1995-12-15
ZA875676B (en) 1988-03-30
ES2081279T3 (es) 1996-03-01
DK400887D0 (da) 1987-07-31

Similar Documents

Publication Publication Date Title
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DK395789A (da) Anvendelse af alfa-aminoboronsyrederivater til fremstilling af et laegemiddel til terapi eller profylakse af virussygdomme
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
NO873923D0 (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
DK400887A (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
NO874200D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
NO875359D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
DK684487A (da) Farmaceutisk praeparat og anvendelse af enkephalinase til fremstilling af et laegemiddel
NO892010D0 (no) Fremgangsmaate for administrering av legemiddelet deprenylslik at farene for bivirkninger minimaliseres.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK